BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 30934972)

  • 1. Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored.
    Mikó E; Kovács T; Sebő É; Tóth J; Csonka T; Ujlaki G; Sipos A; Szabó J; Méhes G; Bai P
    Cells; 2019 Mar; 8(4):. PubMed ID: 30934972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study.
    Plaza-Díaz J; Álvarez-Mercado AI; Ruiz-Marín CM; Reina-Pérez I; Pérez-Alonso AJ; Sánchez-Andujar MB; Torné P; Gallart-Aragón T; Sánchez-Barrón MT; Reyes Lartategui S; García F; Chueca N; Moreno-Delgado A; Torres-Martínez K; Sáez-Lara MJ; Robles-Sánchez C; Fernández MF; Fontana L
    BMC Cancer; 2019 May; 19(1):495. PubMed ID: 31126257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiome and breast cancer: a review.
    Chen J; Douglass J; Prasath V; Neace M; Atrchian S; Manjili MH; Shokouhi S; Habibi M
    Breast Cancer Res Treat; 2019 Dec; 178(3):493-496. PubMed ID: 31456069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Microbiome-Estrogen Connection and Breast Cancer Risk.
    Parida S; Sharma D
    Cells; 2019 Dec; 8(12):. PubMed ID: 31847455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer and Its Relationship with the Microbiota.
    Fernández MF; Reina-Pérez I; Astorga JM; Rodríguez-Carrillo A; Plaza-Díaz J; Fontana L
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30110974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights.
    Parida S; Sharma D
    Cells; 2020 Apr; 9(5):. PubMed ID: 32354130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unexpected link: The role of mammary and gut microbiota on breast cancer development and management (Review).
    Toumazi D; El Daccache S; Constantinou C
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational studies on bacterial secondary metabolites against breast cancer.
    Ravnik Z; Muthiah I; Dhanaraj P
    J Biomol Struct Dyn; 2021 Nov; 39(18):7056-7064. PubMed ID: 32779523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Microbiome as a Component of the Tumor Microenvironment.
    Kovács T; Mikó E; Ujlaki G; Sári Z; Bai P
    Adv Exp Med Biol; 2020; 1225():137-153. PubMed ID: 32030653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer.
    Parida S; Sharma D
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):392-405. PubMed ID: 30981803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota composition modifies fecal metabolic profiles in mice.
    Zhao Y; Wu J; Li JV; Zhou NY; Tang H; Wang Y
    J Proteome Res; 2013 Jun; 12(6):2987-99. PubMed ID: 23631562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota homeostasis restoration may become a novel therapy for breast cancer.
    Feng ZP; Xin HY; Zhang ZW; Liu CG; Yang Z; You H; Xin HW
    Invest New Drugs; 2021 Jun; 39(3):871-878. PubMed ID: 33454868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.
    Behr C; Slopianka M; Haake V; Strauss V; Sperber S; Kamp H; Walk T; Beekmann K; Rietjens IMCM; van Ravenzwaay B
    Toxicol Appl Pharmacol; 2019 Jan; 363():79-87. PubMed ID: 30502395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness.
    Mikó E; Vida A; Kovács T; Ujlaki G; Trencsényi G; Márton J; Sári Z; Kovács P; Boratkó A; Hujber Z; Csonka T; Antal-Szalmás P; Watanabe M; Gombos I; Csoka B; Kiss B; Vígh L; Szabó J; Méhes G; Sebestyén A; Goedert JJ; Bai P
    Biochim Biophys Acta Bioenerg; 2018 Sep; 1859(9):958-974. PubMed ID: 29655782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut and Breast Microbiota as Endocrine Regulators of Hormone Receptor-positive Breast Cancer Risk and Therapy Response.
    Arnone AA; Cook KL
    Endocrinology; 2022 Nov; 164(1):. PubMed ID: 36282876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota and Breast Cancer.
    Mani S
    Prog Mol Biol Transl Sci; 2017; 151():217-229. PubMed ID: 29096895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.
    Kwa M; Plottel CS; Blaser MJ; Adams S
    J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27107051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resident bacteria in breast cancer tissue: pathogenic agents or harmless commensals?
    O'Connor H; MacSharry J; Bueso YF; Lindsay S; Kavanagh EL; Tangney M; Clyne M; Saldova R; McCann A
    Discov Med; 2018 Sep; 26(142):93-102. PubMed ID: 30399327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.